T5	Effect 0 4	ARDS
T7	Treatment 30 132	the administration of other monoclonal antibodies, such as infliximab, gemtuzumab ozogamicin, and OKT3
T8	Speculation_cue 140 148	believed
T9	Drug 58 79	monoclonal antibodies
T10	Drug 89 99	infliximab
T11	Drug 101 122	gemtuzumab ozogamicin
T12	Drug 128 132	OKT3
